Case Reports

Teclistamab for heavily pretreated relapsed / refractory POEMS syndrome

Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris
Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris
Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris
Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris
Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris
Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris
Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris
Department of Pathology, Saint-Louis Hospital, AP-HP, Paris
Université Paris Cité, Paris, France; Department of Nuclear Medicine, Saint Louis Hospital, AP-HP, Paris
Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris
Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris, France; Université Paris Cité, Paris
Immuno-Hematology, Saint Louis Hospital, AP-HP, Paris
Haematologica Early view Jul 3, 2025 https://doi.org/10.3324/haematol.2025.287606